Milestone Achieved as Immunotherapeutic Agent Under Investigation for the Treatment of Ovarian Cancer Added to Asset PortfolioTAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB ...

Wound Healing and Limb Salvaging Technology Adds to Company’s Asset Portfolio Focused on Unmet Medical NeedsTAMPA, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical ...

TAMPA, Fla., Dec. 29, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (HCYT), a medical biosciences company, announced today that the Company completed its acquisition of SkinDisc™. “The completed ...

--H-CYTE Inc. the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute, announces it has raised $6 million in new funding.

Shares of H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) traded down 49.5% on Tuesday .The company traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during mid-day ...